ArticleCPT: pharmacometrics & systems pharmacology2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple Myeloma.
Fernando Carreño et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.